Nathan J. Dowden, President & COO: Entrada Therapeutics TRDA Sell · Filed 24/08/20

Trade details

Type: Insider sale
Amount: $432,434.7
Shares · price: 26,595 sh · $16.26 a share
Held after: 130,609 sh
Stock: Entrada Therapeutics TRDA
Person: Nathan J. DowdenPresident & COO
Trade date: 24/08/16
Filed: 24/08/20
Days to filing: 4 days

Sold 16.9% of holdings

Share of holding sold: 16.9%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/17~24/09/15

Nathan J. Dowden's recent trades

Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$230K
15,000 sh
$230K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$217.5K
15,000 sh
$217.5K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$155.2K
11,894 sh
$155.2K
Filed 03/11
Traded 03/10
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$40.6K
3,116 sh
$40.6K
Filed 03/11
Traded 03/09
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$188.8K
15,010 sh
$188.8K
Filed 03/09
Traded 03/09

Nathan J. Dowden, COO — sold $432.4K of Entrada Therapeutics TRDA · 16.9% of holdings · 10b5-1 plan | Whalegun